Data / Form D filings / Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc.: Form D filings
Afferent Pharmaceuticals, Inc., a pharmaceuticals company in San Mateo, CA, filed 3 Form D notices with the SEC between 2009 and 2015. The latest, on July 14, 2015, reports $55 million sold of a $55 million offering to 17 investors.
Find out what Afferent Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2929 Campus Drive, Suite 230, San Mateo, CA, 94403
- Phone
- (650) 286-1276
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1476010
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2015 | New notice | $54,999,986 | $54,999,986 | $0 | 17 | Jul 1, 2015 | sec.gov |
| Dec 18, 2009 | New notice | $23,000,000 | $3,000,000 | $20,000,000 | 6 | Dec 9, 2009 | sec.gov |
| Nov 5, 2009 | New notice | $150,000 | $150,000 | $0 | 6 | Oct 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Sereda Starr | Director | |
| Michael Sereda Kitt | Executive Officer | |
| Arthur Sereda Pappas | Director | |
| Anthony Sereda Ford | Executive Officer | |
| Kathleen Sereda Glaub | Executive Officer, Director | |
| Peter Sereda Hirth | Director | |
| Liam Sereda Ratcliffe | Director | |
| Jesse Sereda Treu | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 13, 2015 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Afferent Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.